Indications

Chronic Hepatitis B (CHB);

used as the immune response potentiator of the vaccine for the immune-damaged people. The target group whose immune system function is restrained includes the elderly and those who accept chronic hemodialysis. This product can enhance the response to viral vaccine, such as the flu vaccine or Hepatitis B vaccine.

Highlights 

Listed in both Chinese pharmacopeia and Martindale pharmacopeia;

The first-line drug listed in "CHB treatment guidelines of asian-pacific area".

2 million vials were sold in China in 2016;

Marketed in South Korea and Hong Kong, under registration in Cambodia, Vietnam and Thailand.

Specification

1.6mg/vial

Packing

1 vial/box

Originator

 SciClone Pharmaceuticals Inc., ZADAXIN ®

Dosage Form 

Freeze-dried powder for injection.